Kestra Medical Technologies (KMTS): Assessing a 20x Sales Valuation After a Recent Double-Digit Daily Gain

Simply Wall St.12-04

Kestra Medical Technologies (KMTS) has quietly delivered a sharp move, jumping about 12% in the latest session even as the stock remains down over the past month but up strongly over the past three ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2588300469?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2025-12-04 15:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588300469","market":"sg","top_or_hot":-1,"title":"Kestra Medical Technologies (KMTS): Assessing a 20x Sales Valuation After a Recent Double-Digit Daily Gain","media":"Simply Wall St.","content":"<div>\n<p>Kestra Medical Technologies (KMTS) has quietly delivered a sharp move, jumping about 12% in the latest session even as the stock remains down over the past month but up strongly over the past three ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-assessing-a-20x-sales-valua\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kestra Medical Technologies (KMTS): Assessing a 20x Sales Valuation After a Recent Double-Digit Daily Gain</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKestra Medical Technologies (KMTS): Assessing a 20x Sales Valuation After a Recent Double-Digit Daily Gain\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-04 15:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-assessing-a-20x-sales-valua><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Kestra Medical Technologies (KMTS) has quietly delivered a sharp move, jumping about 12% in the latest session even as the stock remains down over the past month but up strongly over the past three ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-assessing-a-20x-sales-valua\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KMTS","symbol_name":"Kestra Medical Technologies Inc","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-assessing-a-20x-sales-valua","article_id":"2588300469","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-kmts/kestra-medical-technologies/news/kestra-medical-technologies-kmts-assessing-a-20x-sales-valua","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2588300469","pubTimestamp":1764832967,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Kestra Medical Technologies (KMTS) has quietly delivered a sharp move, jumping about 12% in the latest session even as the stock remains down over the past month but up strongly over the past three months.\nSee our latest analysis for Kestra Medical Technologies.\nThat mix of a 12.21% one-day share price return and a softer 7-day share price return of minus 4.37 percent sits alongside a still impressive 51.88 percent 90-day share price return. This suggests medium-term momentum is building from...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"KMTS":"Kestra Medical Technologies Inc","BK4082":"医疗保健设备"},"translate_title":"Kestra Medical Technologies(KMTS)：在最近每日两位数增长后，评估20倍的销售估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KMTS":1},"content_text":"Kestra Medical Technologies (KMTS) has quietly delivered a sharp move, jumping about 12% in the latest session even as the stock remains down over the past month but up strongly over the past three months. See our latest analysis for Kestra Medical Technologies. That mix of a 12.21% one-day share price return and a softer 7-day share price return of minus 4.37 percent sits alongside a still impressive 51.88 percent 90-day share price return. This suggests medium-term momentum is building from a choppy base around the current 25.82 dollars level. If Kestra’s move has you rethinking the healthcare space, this is a good moment to explore other names via our curated set of healthcare stocks. With Kestra trading just below its consensus target despite rapid revenue growth but ongoing losses, investors now face a key question: is this a mispriced innovator in cardiac care, or has the market already baked in its next leg of growth? AdvertisementPrice to Sales of 20x: Is It Justified? At roughly 26 dollars a share, Kestra is trading at a rich price to sales level that signals investors are paying up well ahead of profits. The price to sales ratio compares a company’s market value to its revenue. It can be a useful yardstick for loss-making, high-growth names where earnings are still negative. For a business like Kestra that is scaling a wearable cardiac platform rather than generating steady profits, this metric becomes a primary shorthand for how much future growth the market is pricing in today. Right now the market is assigning Kestra a price to sales ratio of about 20 times, well above both the US Medical Equipment industry average of roughly 3.4 times and a peer group closer to 4.9 times. That premium also exceeds an estimated fair price to sales multiple of 3.4 times, suggesting the current valuation could have meaningful room to compress if execution or growth expectations are challenged. Explore the SWS fair ratio for Kestra Medical Technologies Result: Price-to-Sales of 20x (OVERVALUED) However, sustained losses and any slowdown in adoption of its wearable cardiac platform could quickly challenge the premium valuation that investors currently support. Find out about the key risks to this Kestra Medical Technologies narrative.  Build Your Own Kestra Medical Technologies Narrative If you see the story differently, or would rather dig into the numbers yourself, you can build a custom view in just a few minutes, Do it your way. A great starting point for your Kestra Medical Technologies research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? Smart investors continually look for the next opportunity, so consider using Simply Wall St’s powerful screener to explore ideas before the market moves.  Explore early stage potential by targeting these 3571 penny stocks with strong financials that already show strong fundamentals instead of waiting until Wall Street focuses on them. Seek exposure to innovation by focusing on these 25 AI penny stocks positioned at the intersection of powerful algorithms and growing demand. Identify potential value by examining these 920 undervalued stocks based on cash flows where current prices may not fully reflect the strength of their underlying cash flows.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Kestra Medical Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588300469","isCrawlerRequest":true}